Mark E. Robson, MD, Clinical Director of the Clinical Genetics Services at Memorial Sloan Kettering Cancer Center, discusses when it is appropriate to go for genetic testing to determine cancer risk.
Mark E. Robson, MD, Clinical Director of the Clinical Genetics Services at Memorial Sloan Kettering Cancer Center, discusses when it is appropriate to go for genetic testing to determine cancer risk.
Robson says that the criteria for genetic testing is becoming broader, and more people are familiar with the process and costs of testing have decreased. However, he notes that not everyone should be tested for every type of malignancy. Genetic testing is most appropriate for people with family history of certain cancers or who experienced certain cancers, such as triple-negative breast cancer or colon cancer, at a young age.
Precision Medicine Advances Represent New Paradigm in Cancer Care
April 12th 2023Precision medicine is a term that has been in our oncology language for years, but changes are occurring quickly. As oncology nurses, we need to learn about genomics and biomarkers and what precision medicine means for patients’ outcomes.